Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT)
| 51.17 Delayed Data As of Jul 08 |  +1.50 / +3.02%Today’s Change | 8.49 Today|||52-Week Range 62.97 | +370.75% Year-to-Date |
Latest ARCT News | Press Releases
| Is This Under-the-Radar Stock a Better Coronavirus Play Than Moderna? Jul 05 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 49.66 |
| Today’s open | 50.00 |
| Day’s range | 48.43 - 51.44 |
| Volume | 631,723 |
| Average volume (3 months) | 676,566 |
| Market cap | $952.7M |
Data as of 3:59pm ET, 07/08/2020
Growth & Valuation
| Earnings growth (last year) | +0.47% |
| Earnings growth (this year) | -22.86% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +31.97% |
| P/E ratio | NM |
| Price/Sales | 6.31 |
| Price/Book | 27.29 |
Competitors
| ---- | ||
| AIMTAimmune Therapeutics... | -0.21 | -1.25% |
| PAHCPhibro Animal Health... | -0.76 | -2.94% |
| ENTAEnanta Pharmaceutica... | -0.14 | -0.28% |
Data as of 3:59pm ET, 07/08/2020
Financials
| Next reporting date | October 5, 2020 |
| EPS forecast (this quarter) | -$0.60 |
| Annual revenue (last year) | $20.8M |
| Annual profit (last year) | -$26.0M |
| Net profit margin | -125.02% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
